Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment

Por um escritor misterioso

Descrição

Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Cancers, Free Full-Text
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
A targeted nanoplatform co-delivery of pooled siRNA and
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Role of natural P-gp inhibitor in the effective delivery for
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Overcoming P-Glycoprotein–Mediated Drug Resistance with Noscapine
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Overcoming multidrug resistance via simultaneous delivery of
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Tenulin and isotenulin inhibit P-glycoprotein function and
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Life, Free Full-Text
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Frontiers Multidrug Resistance in Cancer: Understanding
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
New Dual P-Glycoprotein (P-gp) and Human Carbonic Anhydrase XII
Inhibit or Evade Multidrug Resistance P-Glycoprotein in Cancer Treatment
Advances in understanding the role of P-gp in doxorubicin
de por adulto (o preço varia de acordo com o tamanho do grupo)